SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syncom Formulations (India) submits newspaper clippings

06 Sep 2019 Evaluate

Syncom Formulations (India) has informed about submission of copy of Newspaper Clippings of Notice for the 31st Annual General Meeting (AGM), E-voting and Book Closure published in Free Press (Mumbai English Edition) & Navshakti Maratha (Mumbai Edition Local in Marathi) on 06th September, 2019. 

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

13.98 -0.01 (-0.07%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: